Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Angelica Peebles - CNBC - 12:30
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

In this article

  • LLY
Follow your favorite stocksCREATE FREE ACCOUNT
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.
Brendan McDermid | Reuters

Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt to crack down on the booming industry of copycat drugs.

In lawsuits filed Wednesday, Lilly accuses the sites — Mochi...
[Short citation of 8% of the original article]